Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2017391.pdf
Reference55 articles.
1. Leiter U, Eigentler T, Garbe C . Epidemiology of skin cancer. Adv Exp Med Biol 2014; 810: 120–140.
2. Harries M, Malvehy J, Lebbe C, Heron L, Amelio J, Szabo Z et al. Treatment patterns of advanced malignant melanoma (stage III-IV) - a review of current standards in Europe. Eur J Cancer 2016; 60: 179–189.
3. Dummer R, Hauschild A, Guggenheim M, Keilholz U, Pentheroudakis G . Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 (Suppl 7): vii86–vii91.
4. Chapuis AG, Lee SM, Thompson JA, Roberts IM, Margolin KA, Bhatia S et al. Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient. J Exp Med 2016; 213: 1133–1139.
5. Matin RN, Chikh A, Chong SL, Mesher D, Graf M, Sanza P et al. p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis. J Exp Med 2013; 210: 581–603.
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors;Oncogene;2024-08-16
2. Characterization of two different alginate-based bioinks and the influence of melanoma growth within;Scientific Reports;2024-06-05
3. Synthesis of folate targeted theranostic cubosomal platform for co-delivery of bismuth oxide and doxorubicin to melanoma in vitro and in vivo;European Journal of Pharmaceutics and Biopharmaceutics;2024-05
4. Transdermal treatment for malignant melanoma by aptamer-modified tetrahedral framework nucleic acid delivery of vemurafenib;Chinese Chemical Letters;2024-04
5. Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence;Cell Death & Disease;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3